Detailed answers about ALPHACELLS BIOTECHNOLOGIES LIMITED, including incorporation, status, business activity, and accounts information.
When was ALPHACELLS BIOTECHNOLOGIES LIMITED founded?
ALPHACELLS BIOTECHNOLOGIES LIMITED was officially incorporated on 19 February 2019 and is registered under company number 11835984. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ALPHACELLS BIOTECHNOLOGIES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ALPHACELLS BIOTECHNOLOGIES LIMITED?
ALPHACELLS BIOTECHNOLOGIES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ALPHACELLS BIOTECHNOLOGIES LIMITED do?
ALPHACELLS BIOTECHNOLOGIES LIMITED operates in the following sectors: 21200 - Manufacture of pharmaceutical preparations, 72110 - Research and experimental development on biotechnology, 74909 - Other professional, scientific and technical activities n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is ALPHACELLS BIOTECHNOLOGIES LIMITED's registered address?
The registered office address of ALPHACELLS BIOTECHNOLOGIES LIMITED is 6 KINGS ROAD, SUTTON, UNITED KINGDOM, SM2 6DG. This is the official address filed with Companies House for legal and statutory correspondence.
Is ALPHACELLS BIOTECHNOLOGIES LIMITED financially stable?
The most recent accounts for ALPHACELLS BIOTECHNOLOGIES LIMITED were made up to 28 February 2025, filed as MICRO ENTITY. Next accounts are due by 30 November 2026.